Related Experiment Videos
Histamine release from rat mast cells sensitized with mouse antiserum
Summary
Researchers investigated histamine release from rat mast cells, finding that some antiallergic drugs block calcium channels. These findings offer insights into mast cell degranulation and potential therapeutic targets.
Area of Science:
- Immunology
- Pharmacology
Background:
- Mast cells play a crucial role in allergic reactions through histamine release.
- Antigen-induced histamine release is a well-studied phenomenon, but non-antigen-induced pathways are less understood.
Purpose of the Study:
- To investigate the mechanisms of antigen-induced and non-antigen-induced histamine release from rat mast cells.
- To evaluate the effects of specific antiallergic drugs on these histamine release pathways.
Main Methods:
- Sensitization of rat peritoneal mast cells in vitro with mouse anti-ovalbumin serum.
- Induction of histamine release using antigen (ovalbumin) and non-antigenic stimuli.
- Treatment of mast cells with antiallergic drugs including quercetin, verapamil, theophylline, and disodium cromoglycate.
Main Results:
- Heat-labile factors in mouse antiserum and normal mouse serum contributed to non-antigen-induced histamine release.
- Phosphatidyl serine and calcium ions (Ca++) induced histamine release in the absence of antigen when mast cells were treated with these factors.
- Quercetin and verapamil were found to primarily block calcium-gate opening during antigen-antibody interactions.
- Theophylline and disodium cromoglycate were observed to inhibit calcium passage through open calcium channels.
Conclusions:
- Non-antigen-induced histamine release involves heat-labile factors and can be modulated by phosphatidyl serine and calcium.
- Antiallergic drugs exhibit distinct mechanisms of action, targeting different stages of calcium influx during mast cell degranulation.
- These findings provide a deeper understanding of mast cell activation and offer potential therapeutic strategies for allergic diseases.